Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -0.21x is 100% above its 5-year average of -217.95x, near the high end of its 5-year range (-859.96x–0.00x).
As of the fiscal period ended Monday, September 30, 2024.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2024 (2024-09-30): -0.21x.
INTEREST COVERAGE RATIO
-0.21x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
-238.60x
INTEREST COVERAGE RATIO AVG 5Y
-217.95x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+99.91%
CURRENT VS 5Y AVG
+99.91%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.64x
median of 470 covered companies
CURRENT VS SECTOR MEDIAN
+96.35%
vs the sector median at left
ENDRA Life Sciences Inc.
Market Cap
$7.96M
Interest Coverage Ratio
-0.21x
TTM Avg
N/A
3Y Avg
-238.60x
5Y Avg
-217.95x
Market Cap
$8.01M
Interest Coverage Ratio
-97.81x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.05M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.13M
Interest Coverage Ratio
-11.17x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.67M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.32M
Interest Coverage Ratio
-17.73x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.42M
Interest Coverage Ratio
-17.26x
TTM Avg
23.36x
3Y Avg
23.36x
5Y Avg
23.36x
Market Cap
$7.34M
Interest Coverage Ratio
-1049.68x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.31M
Interest Coverage Ratio
-924.78x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | $7.96M | -0.21x | N/A | -238.60x | -217.95x |
| GT Biopharma, Inc. (GTBP)vs › | $8.01M | -97.81x | N/A | N/A | N/A |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.05M | N/A | N/A | N/A | N/A |
| HeartSciences Inc. (HSCS)vs › | $8.13M | -11.17x | N/A | N/A | N/A |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.67M | N/A | N/A | N/A | N/A |
| DataMEDS AI, Inc. (MEDS)vs › | $8.32M | -17.73x | N/A | N/A | N/A |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.42M | -17.26x | 23.36x | 23.36x | 23.36x |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.34M | -1049.68x | N/A | N/A | N/A |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | -924.78x | N/A | N/A | N/A |
| Skye Bioscience, Inc. (SKYE)vs › | $7.29M | N/A | N/A | N/A | N/A |
Interest Coverage
-0.2x
Debt/Equity
0.07
Current Ratio
7.10
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2024-09-30 | -0.21x |
| 2023-03-31 | -859.96x |
| 2022-09-30 | -148.50x |
| 2022-06-30 | -184.35x |
| 2022-03-31 | 0.00x |
| 2020-06-30 | -749.42x |
| 2020-03-31 | -13.57x |
| 2019-12-31 | -1.92x |
| 2019-09-30 | -3.63x |
| 2018-09-30 | -6.24x |
| 2017-09-30 | -449.62x |
| 2017-06-30 | -2.83x |
| 2016-09-30 | -1.62x |
| 2016-06-30 | -2.11x |
